Table 4.

The 39-item Parkinson's disease questionnaire of patients with PD at baseline and after 12 weeks of intervention.

PDQ-39	Baseline (V0)	Range	Post-12 weeks (V1)	Range	p	Change (V1-V0)	ES
Single index	19.86 ± 9.6	3.39–40.42	14.18 ± 8.61	3.44–40.42	0.031	−5.68 ± 8.55	0.664
Mobility	19.2 ± 12.33	2.5–45	13.1 ± 13.43	0–62.5	0.049	−6.1 ± 12.73	0.479
Activities of daily living	17.83 ± 15.24	0–54.17	11.34 ± 8.8	0–29.17	0.039	−6.5 ± 11.85	0.548
Emotional well-being	19.67 ± 16.07	0–75	13.67 ± 16.65	0–75	0.077	−6 ± 10.96	0.547
Stigma	23.5 ± 17.33	0–75	14.75 ± 13.12	0–43.75	0.039	−8.75 ± 16.73	0.523
Social support	7.67 ± 7.95	0–25	6 ± 8.51	0–25	0.344	−1.67 ± 5.89	0.283
Cognitions	28 ± 17.96	0–62.5	21.25 ± 16.54	0–62.5	0.021	−6.75 ± 11.11	0.608
Communication	21 ± 16.69	0–58.33	15.33 ± 12.88	0–50	0.146	−5.67 ± 13.55	0.418
Bodily discomfort	22 ± 16.3	0–66.67	18 ± 12.43	0–41.67	1.000	−4 ± 15.98	0.250

Change in negative value indicates improvement. Mean ± SD; p: signed rank test, α = 0.05, 2-tailed; ES: 0.2 small effect, 0.5 medium effect, 0.8 large effect.

PDQ-39, 39-item Parkinson's disease questionnaire; ES, effect size.